Rare Genetic Combination in Gastrointestinal Tumor Offers New Insights Into Precision Cancer Care
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive tract. Although many GISTs can be effectivel...
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Oncotarget
Traditional scholarly journal with open free-access. Topics on Oncology, Aging, Pathology, Immunology, Microbiology, Autophagy, Cell Death, and Chromosome
Oncotarget Podcast Guide
Listen to Oncotarget, a Science & Medicine podcast by Oncotarget Podcast. Stream 515 episodes in English, follow new audio stories, and play episodes online on Radio and Podcast.
Show Topic
Browse this show under Science & Medicine podcasts.
Episodes
20 episodes are loaded now from a catalog of 515. More episodes can be opened from this page.
Discover More
Explore Science & Medicine podcasts, India podcasts and English podcasts.
Episodes
20 of 515 episodes
Rare Benign Kidney Tumor Case Highlights Value of Biopsy and Minimally Invasive Treatment
BUFFALO, NY – July 6, 2026 – A new #casereport was #published in Volume 17 of Oncotarget on July 2, 2026, titled “Renal oncocytoma: Α case r...
Targeted Therapies Coincided With Dramatic Decline in Multiple Myeloma Mortality in the US
Multiple myeloma is the second most common blood cancer in the United States and has long been considered a difficult disease to treat. For...
TRAIL-R2 Silencing Linked to More Aggressive Breast Cancer
BUFFALO, NY – June 24, 2026 – A new research paper was published in Volume 17 of Oncotarget on June 9, 2026, titled “TRAIL-R2 in the shadows...
Protein Linked to Melanoma Growth May Suppress the Body’s Natural Anti-Tumor Immune Response
BUFFALO, NY – June 17, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on June 8, 2026, titled “DHHC3 interferes with...
PDX1 May Link Metabolic Dysfunction to Prostate Cancer Progression
Prostate cancer is the most commonly diagnosed cancer among men and remains a leading cause of cancer-related death worldwide. While age, fa...
HPV Vaccine Shows Safety but Uncertain Benefit in Preventing Head & Neck Cancer Recurrence
BUFFALO, NY – June 15, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on June 5, 2026, titled “A randomized double-b...
Experimental Compounds Trigger Cancer Cell Death in KRAS-Driven Pancreatic Cancer
BUFFALO, NY – June 8, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on June 3, 2026, titled “The anticancer effects...
Cancer Care Often Overlooked in Humanitarian Crises
Cancer is increasingly recognized as a major global health challenge, yet for people living through war, displacement, and humanitarian cris...
Protein in Tumor Microenvironment Found to Promote Colorectal Cancer Growth and Immune Evasion
BUFFALO, NY – June 2, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on May 20, 2026, titled “Microenvironmental CTH...
Immune Checkpoint Inhibitors May Improve Outcomes in High-Risk Solid Tumors
Cancer immunotherapy has transformed the treatment landscape for many advanced cancers over the past decade. Drugs targeting the PD-1 and PD...
Rare Laryngeal Leiomyosarcoma Successfully Treated with Surgery and Adjuvant Chemotherapy
BUFFALO, NY – May 13, 2026 – A new #casereport was #published in Volume 17 of Oncotarget on May 4, 2026, titled “Laryngeal leiomyosarcoma: A...
Agentic AI Systems May Transform Nutritional Care in Oncology
BUFFALO, NY – May 11, 2026 – A new #editorial was #published in Volume 17 of Oncotarget on May 4, 2026, titled “Artificial intelligence in n...
Rare Dual-Mutation GIST Responds to Targeted Therapy, Challenging Established Tumor Biology
BUFFALO, NY – May 6, 2026 – A new #casereport was #published in Volume 17 of Oncotarget on May 4, 2026, titled “Small bowel GIST harboring c...
Mapping the Hidden Structure of Glioma Research: What Are We Missing?
Glioma research has evolved rapidly over the past decade, driven by breakthroughs in molecular biology, imaging technologies, and computatio...
Targeted Therapies Drive Long-Term Decline in Multiple Myeloma Mortality in the U.S.
BUFFALO, NY – April 29, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on April 28, 2026, titled “Targeted therapeut...
SCD1 Inhibition Strategy Shows Potent Synergy with Regorafenib and Metformin in Tumor Cell Killing
Cancer has long been understood through a variety of biological frameworks, including genetic mutations, dysregulated signaling pathways, an...
Epigenetic Dysregulation of PDX1 Drives Prostate Cancer Progression
BUFFALO, NY – April 15, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Epigenetic dysregu...
Cancer Care in Conflict Zones Remains Critically Neglected
BUFFALO, NY – April 13, 2026 – A new #review was #published in Volume 17 of Oncotarget on March 31, 2026, titled “Cancer without borders: Po...
Oncotarget Editorial Highlights Advances in Scientific Integrity and Publishing Transparency
BUFFALO, NY – April 10, 2026 – A new #editorial perspective was #published in Volume 17 of Oncotarget on April 8, 2026, titled “Oncotarget:...